Van Biesen W - Search Results

1

Questioning the Pathogenic Role of the GLA p.Ala143Thr "Mutation" in Fabry Disease: Implications for Screening Studies and ERT.

Terryn W, Vanholder R, Hemelsoet D, Leroy BP, Van Biesen W, De Schoenmakere G, Wuyts B, Claes K, De Backer J, De Paepe G, Fogo A, Praet M, Poppe B. Terryn W, et al. Among authors: van biesen w. JIMD Rep. 2013;8:101-8. doi: 10.1007/8904_2012_167. Epub 2012 Jul 29. JIMD Rep. 2013. PMID: 23430526 Free PMC article.

2

Prevalence of Fabry disease in a predominantly hypertensive population with left ventricular hypertrophy.

Terryn W, Deschoenmakere G, De Keyser J, Meersseman W, Van Biesen W, Wuyts B, Hemelsoet D, Pascale H, De Backer J, De Paepe A, Poppe B, Vanholder R. Terryn W, et al. Among authors: van biesen w. Int J Cardiol. 2013 Sep 10;167(6):2555-60. doi: 10.1016/j.ijcard.2012.06.069. Epub 2012 Jul 16. Int J Cardiol. 2013. PMID: 22805550 Clinical Trial.

3

Fabry nephropathy: indications for screening and guidance for diagnosis and treatment by the European Renal Best Practice.

Terryn W, Cochat P, Froissart R, Ortiz A, Pirson Y, Poppe B, Serra A, Van Biesen W, Vanholder R, Wanner C. Terryn W, et al. Among authors: van biesen w. Nephrol Dial Transplant. 2013 Mar;28(3):505-17. doi: 10.1093/ndt/gfs526. Epub 2012 Dec 12. Nephrol Dial Transplant. 2013. PMID: 23234755 Free article.

4

The role of peritoneal dialysis as first modality in an integrative approach to patients with end-stage renal disease.

Lameire N, Van Biesen W, Vanholder R. Lameire N, et al. Among authors: van biesen w. Perit Dial Int. 2000;20 Suppl 2:S134-41. Perit Dial Int. 2000. PMID: 10911659 Review. No abstract available.

5

Incidence of infectious morbidity and mortality in dialysis patients.

Vanholder R, Van Biesen W. Vanholder R, et al. Among authors: van biesen w. Blood Purif. 2002;20(5):477-80. doi: 10.1159/000063556. Blood Purif. 2002. PMID: 12207097 Review.

6

Intermittent hemodialysis for renal replacement therapy in intensive care: new evidence for old truths.

Van Biesen W, Veys N, Vanholder R. Van Biesen W, et al. Contrib Nephrol. 2007;156:304-8. doi: 10.1159/000102120. Contrib Nephrol. 2007. PMID: 17464140 Review.

7

Treating potassium disturbances: kill the killers but avoid overkill.

Vanholder R, Van Biesen W, Nagler EV. Vanholder R, et al. Among authors: van biesen w. Acta Clin Belg. 2019 Aug;74(4):215-228. doi: 10.1080/17843286.2018.1531206. Epub 2018 Oct 24. Acta Clin Belg. 2019. PMID: 30353786 Review.

8

Contributing factors to the inhibition of phagocytosis in hemodialyzed patients.

Vanholder R, Van Biesen W, Ringoir S. Vanholder R, et al. Among authors: van biesen w. Kidney Int. 1993 Jul;44(1):208-14. doi: 10.1038/ki.1993.232. Kidney Int. 1993. PMID: 8355462 Free article.

9

Recent developments in osmotic agents for peritoneal dialysis.

Van Biesen W, Vanholder R, Lameire N. Van Biesen W, et al. Adv Ren Replace Ther. 1998 Jul;5(3):218-31. doi: 10.1016/s1073-4449(98)70035-4. Adv Ren Replace Ther. 1998. PMID: 9686633

10

The impact of the pre-transplant renal replacement modality on outcome after cadaveric kidney transplantation: the ghent experience.

van Biesen W, Veys N, Vanholder R, Lameire N. van Biesen W, et al. Contrib Nephrol. 2006;150:254-258. doi: 10.1159/000093613. Contrib Nephrol. 2006. PMID: 16721018 Review.

There is evidence that PD positively impacts on the outcome after transplantation [Van Loo, A.A. et al: J Am Soc Nephrol 1998;9:473-481], an effect that could be attributed to a more stable fluid homeostasis, but also to an independent effect of biocompatibility of the dia …

There is evidence that PD positively impacts on the outcome after transplantation [Van Loo, A.A. et al: J Am Soc Nephrol 1998;9:473-4 …

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

463 results

Search Page